FindTrial
Sign In

A study to compare the efficacy of Local Injection of PRP and Corticosteroid in the Management of Heel Pain (Plantar Fasciitis)

Comparison of Local Injection of Autologus Platelet Rich Plasma versus Corticosteroid in the Management of Plantar Fasciitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/016952
Enrollment
70
Registered
2019-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M722- Plantar fascial fibromatosis

Interventions

Intervention1: Autologus Platelet Rich Plasma (PRP): This group of patients will be treated by 3ml autologus Platelet rich Plasma injection in the plantar fascia. Control Intervention1: Corticosteroid

Sponsors

Employees State Insurance Corporation Ministry of Labour Employment Government of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Failure of conservative treatment for atleast 3months

Exclusion criteria

Exclusion criteria: Any previous local injection for heel pain Any history of surgery for heel pain Associated pathology involving the foot and ankle Patients with systemic disorder like uncontrolled diabetes mellitus, rheumatoid arthritis, hematological disease or gout Any local skin pathology Any trauma to the foot and ankle

Design outcomes

Secondary

MeasureTime frame
American Orthopaedic Foot & Ankle Society Score (AOFAS)Timepoint: 2week, 1month, 3month, 6month;VAS ( Visual Analogue Score)Timepoint: 2weeks, 1month, 3month—

Primary

MeasureTime frame
Visual Analogue Score (VAS)Timepoint: 6 month—

Countries

India

Contacts

Public ContactRajat Gupta

ESIC PGIMSR

doc.krriss@gmail.com09461021688

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026